Unlock full details of this profile with our free Lite plan!
Sign Up and Get Free AccessAbout Vivo Capital
Vivo Capital is a private equity firm founded in 1996. It is primarily based in Palo Alto, United States. As of Jun 2025, Vivo Capital is an active investor with a portfolio of 214 companies, comprising 211 funding rounds and 4 acquisitions. In the last 12 months, it has participated in 4 funding rounds. The firm primarily invests in companies based in United States and China. Its portfolio is spread across a wide range of sectors from Life Sciences to Healthcare. Its latest investment was a $125M Post IPO round in ORIC Pharmaceuticals on May 28, 2025 which also saw participation from SR One, Point72 and other investors.
Overall Vivo Capital portfolio has seen 1 unicorn, 80 IPOs and 60 acquisitions including key companies like Advanced Accelerator Applications, Amyris and Haier. A lot of funds co-invest with Vivo Capital, with names like RA Capital Management sharing a substantial percentage of its portfolio.
Vivo Capital has a team of 68 people, including 18 partners.
Key Metrics
Founded Year
1996
Location
Palo Alto, United States
Portfolio Companies
Portfolio Sectors
Portfolio Locations
Acquisition Deals
Investment Deals
Vivo Capital's Portfolio
Vivo Capital has a portfolio of 214 companies. They have invested in a total of 211 companies. Their most recent investment was in ORIC Pharmaceuticals (Post IPO round) on May 28, 2025. They have acquired 4 companies. Their latest acquisition was of Serán BioScience on Jan 08, 2021.Team profile of Vivo Capital
Vivo Capital has a team of 68 members including 18 Partners, 4 Venture Partners and 19 Principals located in United States, China and 4 more locations. Vivo Capital's team does not sit on the board of any company as of now.Here is a list of top team members in Vivo Capital:
Name | Designation | Location | Board Memberships | Contact details |
|---|---|---|---|---|
Partner | Palo Alto | - | - | |
Partner | Chaoyang | - | - | |
Partner | Singapore | - | - | |
Partner | Palo Alto | - | - | |
Partner | Palo Alto | - | - | |
Partner | Menlo Park | - | - | |
Partner | Palo Alto | - | - | |
Partner | Palo Alto | - | - | |
Partner | Shanghai | - | - | |
Partner | Palo Alto | - | - | |
Partner | Oxford | - | - |
Co-investors of Vivo Capital
Over the past 29 years, 289 investors have co-invested in Vivo Capital's portfolio companies.
- Top Co-investors of Vivo Capital: 289 investors entered a company along with Vivo Capital. These include investors like RA Capital Management (23 companies).
Vivo Capital News
•
CytomX Therapeutics Announces $100 Million Common Stock OfferingBenzinga•May 12, 2025•CytomX Therapeutics, Longitude Capital, Orbimed, Venrock and 4 others
•
Vivo Capital Closes Public Fund with Over $740 Million in CommitmentsBusiness Wire•May 07, 2025•Vivo Capital
•
Cathay United Bank, First Financial Investments, and Vivo Capital launch Taiwan’s first biotech private equity fundCnyes•Feb 07, 2025•Cathay United Bank, , Vivo Capital
•
Chentai New Materials secures funding from Proxima Ventures & Zhongxin Capital, with Kaicheng Capital advising.PencilNews•Jan 16, 2025•Trendtec, Vivo Capital, CICC, Proxima Ventures
•
Trevi Therapeutics Announces Pricing of $50 Million Underwritten OfferingPR Newswire•Dec 16, 2024•Trevi Therapeutics, Adage Capital Management, Frazier Life Sciences, Logos and 6 others
•
Cidara Therapeutics Announces $105 Million Private PlacementGlobeNewswire•Nov 21, 2024•Cidara Therapeutics, Venrock, Check Point Software, Adage Capital Management and 5 others
•
Agrolend receives R$300 million investment from Vivo VenturesMinha Operadora•Oct 27, 2024•Agrolend, Vivo Capital, Creation Investments, Syngenta Group and 3 others
•
Agrolend obtains nearly €50M in a Series C investment roundEl Referente•Oct 21, 2024•Agrolend, Creation Investments, Syngenta Group, Vivo Capital and 12 others
•
Vivo announces R$8.8 million stake in Agrolend, an agricultural fintechTerra•Oct 21, 2024•Vivo Capital, Agrolend
•
Vivo Ventures announces an investment of $ 1.5 million in AgrolendTele.Síntese•Oct 18, 2024•Vivo Capital, Agrolend